» Articles » PMID: 25763563

Increased Gut Microbiota Diversity and Abundance of Faecalibacterium Prausnitzii and Akkermansia After Fasting: a Pilot Study

Overview
Publisher Springer
Specialty General Medicine
Date 2015 Mar 13
PMID 25763563
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Background: An impaired gut microbiota has been reported as an important factor in the pathogenesis of obesity. Weight reduction has already been mentioned to improve gut microbial subpopulations involved in inflammatory processes, though other subpopulations still need further investigation. Thus, weight reduction in the context of a fasting program together with a probiotic intervention may improve the abundance and diversity of gut microbiota.

Methods: In this pilot study, overweight people underwent a fasting program with laxative treatment for 1 week followed by a 6 week intervention with a probiotic formula. Gut microbiota were analyzed on the basis of 16s rDNA with a quantitative real time polymerase chain reaction. Additionally, a food frequency questionnaire with questions about nutritional behavior, lifestyle, and physical activity was administered before and after the intervention.

Results: We observed an increase in microbial diversity over the study period. No significant changes in abundance of total bacteria, or of Bacteroidetes, Prevotella, Clostridium cluster XIVa, or Clostridium cluster IV were found, although Faecalibacterium prausnitzii showed an increase over the study period. In addition, Akkermanisa and Bifidobacteria increased in abundance due to intervention. The inflammation-associated gut microbes Enterobacteria and Lactobacilli increased during the first week and then declined by the end of the intervention. Two-thirds of the study participants harbored Archaea. No significant improvements of eating habits were reported, although physical activity improved due to the intervention.

Conclusions: Our results show that caloric restriction affects gut microbiota by proliferating mucin-degrading microbial subpopulations. An additional intervention with a probiotic formula increased probiotic-administered gut microbial populations.

Citing Articles

The role of in maintaining health: a bibliometric study.

Gao F, Cheng C, Li R, Chen Z, Tang K, Du G Front Med (Lausanne). 2025; 12:1484656.

PMID: 39967592 PMC: 11833336. DOI: 10.3389/fmed.2025.1484656.


Dietary Restrictions and Cancer Prevention: State of the Art.

Caprara G, Pallavi R, Sanyal S, Pelicci P Nutrients. 2025; 17(3).

PMID: 39940361 PMC: 11820753. DOI: 10.3390/nu17030503.


Intermittent fasting modulates human gut microbiota diversity in a phenotype-dependent manner: a systematic review.

Pramono A, Ardiaria M, Limijadi E, Noer E, Lestari E, Siswanto F Biosci Microbiota Food Health. 2024; 43(3):170-182.

PMID: 38966051 PMC: 11220331. DOI: 10.12938/bmfh.2023-111.


Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications.

Facchin S, Bertin L, Bonazzi E, Lorenzon G, de Barba C, Barberio B Life (Basel). 2024; 14(5).

PMID: 38792581 PMC: 11122327. DOI: 10.3390/life14050559.


: a potential candidate for ameliorating metabolic diseases.

Niu H, Zhou M, Zogona D, Xing Z, Wu T, Chen R Front Immunol. 2024; 15:1370658.

PMID: 38571945 PMC: 10987721. DOI: 10.3389/fimmu.2024.1370658.


References
1.
Dridi B, Raoult D, Drancourt M . Archaea as emerging organisms in complex human microbiomes. Anaerobe. 2011; 17(2):56-63. DOI: 10.1016/j.anaerobe.2011.03.001. View

2.
Quigley E, Flourie B . Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil. 2007; 19(3):166-72. DOI: 10.1111/j.1365-2982.2006.00879.x. View

3.
Derrien M, Vaughan E, Plugge C, de Vos W . Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004; 54(Pt 5):1469-1476. DOI: 10.1099/ijs.0.02873-0. View

4.
Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende D . Enterotypes of the human gut microbiome. Nature. 2011; 473(7346):174-80. PMC: 3728647. DOI: 10.1038/nature09944. View

5.
Png C, Linden S, Gilshenan K, Zoetendal E, McSweeney C, Sly L . Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010; 105(11):2420-8. DOI: 10.1038/ajg.2010.281. View